[Topical glucocorticoid therapy].
D000152:Acne Vulgaris / Q000139:chemically induced; D000273:Adipose Tissue / Q000187:drug effects; D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D007270:Injections, Intra-Articular / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D011693:Purpura / Q000188:drug therapy; D012867:Skin / Q000187:drug effects; D012871:Skin Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000175:diagnosis; D013684:Telangiectasis / Q000139:chemically induced; D014945:Wound Healing / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids
Zur Problematik der topischen Glucocorticoidtherapie